Literature DB >> 19088431

Modulation of Src activity by low molecular weight protein tyrosine phosphatase during osteoblast differentiation.

Willian F Zambuzzi1, José M Granjeiro, Kaushal Parikh, Saravanan Yuvaraj, Maikel P Peppelenbosch, Carmen V Ferreira.   

Abstract

BACKGROUND: Src kinase plays a critical role in bone metabolism, particularly in osteoclasts. However, the ability of Src kinase to modulate the activity of other bone cells is less well understood. In this work, we examined the expression and activity of Src and low molecular weight protein tyrosine phosphatase (LMWPTP) during osteoblast differentiation and assessed the modulation of Src kinase by LMWPTP.
METHODS: Differentiation of MC3T3-E1 pre-osteoblasts was induced by incubation with ascorbic acid and beta-glycerophosphate for up to 28 days. Src phosphorylation and LMWPTP expression were analyzed by immunoblotting. Src dephosphorylation in vitro was assessed by incubating immunoprecipitated Src with LMWPTP followed by assay of the residual Src activity using Sam68 as substrate. The importance of LMWPTP in Src dephosphorylation was confirmed by silencing pre-osteoblasts with siRNA-LMWPTP and then assessing Src phosphorylation.
RESULTS: Pre-osteoblast differentiation was accompanied by a decrease in phosphorylation of the activator site of Src and an increase in phosphorylation of the inhibitory site. The expression of total Src was unaltered, indicating that post-translational modifications play a pivotal role in Src function. LMWPTP expression was higher in periods when the activator site of Src was dephosphorylated. LMWPTP dephosphorylated pY(527)-Src and pY(416)-Src in vitro, with greater specificity for pY(527)Src. Activation of LMWPTP produced strong activation of Src mediated by fast dephosphorylation of pY(527)-Src, followed by slower deactivation of this kinase via dephosphorylation of pY(416)Src.
CONCLUSION: These results provide new insight into the mechanisms governing the dynamics of Src activity during osteoblast differentiation. A fuller understanding of these mechanisms will improve our knowledge of bone metabolism and of the regulation of Src in other types of cells. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088431     DOI: 10.1159/000185506

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  16 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 2.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

3.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

Review 4.  Zinc and the ERK kinases in the developing brain.

Authors:  J R Nuttall; P I Oteiza
Journal:  Neurotox Res       Date:  2011-11-18       Impact factor: 3.911

Review 5.  The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis.

Authors:  Irina Alho; Luís Costa; Manuel Bicho; Constança Coelho
Journal:  Tumour Biol       Date:  2013-04-14

Review 6.  Low molecular weight protein tyrosine phosphatase as signaling hub of cancer hallmarks.

Authors:  Alessandra V S Faria; Emanuella Maria Barreto Fonseca; Helon Guimarães Cordeiro; Stefano Piatto Clerici; Carmen Veríssima Ferreira-Halder
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

7.  Spatial and temporal alterations in protein structure by EGF regulate cryptic cysteine oxidation.

Authors:  Jessica B Behring; Sjoerd van der Post; Arshag D Mooradian; Matthew J Egan; Maxwell I Zimmerman; Jenna L Clements; Gregory R Bowman; Jason M Held
Journal:  Sci Signal       Date:  2020-01-21       Impact factor: 8.192

8.  Laser and LED photobiomodulation effects in osteogenic or regular medium on rat calvaria osteoblasts obtained by newly forming bone technique.

Authors:  Matheus Völz Cardoso; Rebeca do Vale Placa; Adriana Campos Passanezi Sant'Ana; Sebastião Luiz Aguiar Greghi; Mariana Schutzer Ragghianti Zangrando; Maria Lucia Rubo de Rezende; Rodrigo Cardoso Oliveira; Carla Andreotti Damante
Journal:  Lasers Med Sci       Date:  2020-06-08       Impact factor: 3.161

9.  Laser and light-emitting diode effects on pre-osteoblast growth and differentiation.

Authors:  Marina Tochetti Pagin; Flávia Amadeu de Oliveira; Rodrigo Cardoso Oliveira; Adriana Campos Passanezi Sant'Ana; Maria Lucia Rubo de Rezende; Sebastião Luiz Aguiar Greghi; Carla Andreotti Damante
Journal:  Lasers Med Sci       Date:  2012-11-24       Impact factor: 3.161

Review 10.  Protein tyrosine phosphatases as potential therapeutic targets.

Authors:  Rong-Jun He; Zhi-Hong Yu; Ruo-Yu Zhang; Zhong-Yin Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.